negative effects of glp 1 drugs Struggling with GLP-1 therapy side effects? You're not alone. This Clinician Guide: Managing Common GLP-1 Receptor Agonist Side provides practical tips on recognizing, preventing and managing gastrointestinal and nutritional side effects Adverse effects of GLP-1 class

While tirzepatide (marketed as Mounjaro or Zepbound ) has shown remarkable results as a dual GIP/GLP-1 receptor agonist, retatrutide takes it a step further by also targeting the glucagon receptor

Palanca A, van Nes F, Pardo F, Ampudia Blasco FJ, Mathieu C (2022) Real-world evidence of efficacy and safety of SGLT2 inhibitors as adjunctive therapy in adults with type 1 diabetes: a European two-center experience

PMID: 29490085

[DOI] [PMC free article] [PubMed] [Google Scholar] 19.Shi S., Ni L., Gao L., Wu X

Nat Rev Mol Cell Biol

In markets where there is state/PMI reimbursement of GLP-1 treatment for obesity (eg the US), retatrutide is likely to be reserved as a second-line GLP-1 for those who have failed to lose sufficient weight with a cheaper alternative (such as semaglutide or tirzepatide)